Literature DB >> 15710247

Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat.

Chava B Pocernich1, H Fai Poon, Debra Boyd-Kimball, Bert C Lynn, Avindra Nath, Jon B Klein, D Allan Butterfield.   

Abstract

The human immunodeficiency virus (HIV)-Tat protein has been implicated in the neuropathogenesis of HIV infection. However, its role in modulating astroglial function is poorly understood. Astrocyte infection with HIV has been associated with rapid progression of dementia. Intracellularly expressed Tat is not toxic to astrocytes. In fact, intracellularly expressed Tat offers protection against oxidative stress-related toxins such as the mitochondrial toxin 3-nitroproprionic acid (3-NP). In the current study, human astrocytes expressing Tat (SVGA-Tat) and vector controls (SVGA-pcDNA) were each treated with the irreversible mitochondrial complex II inhibitor 3-NP. Proteomics analysis was utilized to identify changes in protein expression levels. By coupling 2D fingerprinting and identification of proteins by mass spectrometry, actin, heat shock protein 90, and mitochondrial single-stranded DNA binding protein were identified as proteins with increased expression, while lactate dehydrogenase had decreased protein expression levels in SVGA-Tat cells treated with 3-NP compared to SVGA-pcDNA cells treated with 3-NP. Oxidative damage can lead to several events including loss in specific protein function, abnormal protein clearance, depletion of the cellular redox-balance and interference with the cell cycle, ultimately leading to neuronal death. Identification of specific proteins protected from oxidation is a crucial step in understanding the interaction of Tat with astrocytes. In the current study, proteomics also was used to identify proteins that were specifically oxidized in SVGA-pcDNA cells treated with 3-NP compared to SVGA-Tat cells treated with 3-NP. We found beta-actin, calreticulin precursor protein, and synovial sarcoma X breakpoint 5 isoform A to have increased oxidation in control SVGA-pcDNA cells treated with 3-NP compared to SVGA-Tat cells treated with 3-NP. These results are discussed with reference to potential involvement of these proteins in HIV dementia and protection of astrocytes against oxidative stress by the HIV virus, a prerequisite for survival of a viral host cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710247     DOI: 10.1016/j.molbrainres.2004.10.024

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  17 in total

1.  HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder.

Authors:  Pichili Vijaya Bhaskar Reddy; Nimisha Gandhi; Thangavel Samikkannu; Zainulabedin Saiyed; Marisela Agudelo; Adriana Yndart; Pradnya Khatavkar; Madhavan P N Nair
Journal:  Neurochem Int       Date:  2011-07-03       Impact factor: 3.921

2.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

3.  Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.

Authors:  Ming Li; Jason M Aliotta; John M Asara; Lynne Tucker; Peter Quesenberry; Michelle Lally; Bharat Ramratnam
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

4.  Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells.

Authors:  Attila Bacsi; Mitchell Woodberry; William Widger; John Papaconstantinou; Sankar Mitra; Johnny W Peterson; Istvan Boldogh
Journal:  Mitochondrion       Date:  2006-08-03       Impact factor: 4.160

5.  Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations.

Authors:  Joseph R Berger; Malcolm Avison; Yunanan Mootoor; Carol Beach
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

6.  Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression.

Authors:  Melissa A Bradley; Shuling Xiong-Fister; William R Markesbery; Mark A Lovell
Journal:  Neurobiol Aging       Date:  2010-10-20       Impact factor: 4.673

7.  Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.

Authors:  Rachel Williams; Honghong Yao; Fuwang Peng; Yanjing Yang; Crystal Bethel-Brown; Shilpa Buch
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

8.  Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting spatial learning deficits.

Authors:  R L Self; K J Smith; T R Butler; J R Pauly; M A Prendergast
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

9.  Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Authors:  Marta J Gonzalez-Hernandez; James D Cavalcoli; Maureen A Sartor; Rafael Contreras-Galindo; Fan Meng; Manhong Dai; Derek Dube; Anjan K Saha; Scott D Gitlin; Gilbert S Omenn; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.